Annual Total Expenses
$799.27 M
+$190.52 M+31.30%
December 31, 2024
Summary
- As of March 12, 2025, BBIO annual total expenses is $799.27 million, with the most recent change of +$190.52 million (+31.30%) on December 31, 2024.
- During the last 3 years, BBIO annual total expenses has risen by +$152.92 million (+23.66%).
- BBIO annual total expenses is now at all-time high.
Performance
BBIO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$227.22 M
+$37.35 M+19.67%
December 31, 2024
Summary
- As of March 12, 2025, BBIO quarterly total expenses is $227.22 million, with the most recent change of +$37.35 million (+19.67%) on December 31, 2024.
- Over the past year, BBIO quarterly total expenses has increased by +$37.35 million (+19.67%).
- BBIO quarterly total expenses is now at all-time high.
Performance
BBIO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
BBIO Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +31.3% | +19.7% |
3 y3 years | +23.7% | +19.7% |
5 y5 years | +160.5% | +19.7% |
BBIO Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +46.4% | at high | +84.1% |
5 y | 5-year | at high | +160.5% | at high | +145.8% |
alltime | all time | at high | +1722.4% | at high | +553.2% |
BridgeBio Pharma Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $799.27 M(+31.3%) | $227.22 M(+19.7%) |
Sep 2024 | - | $189.86 M(+8.6%) |
Jun 2024 | - | $174.82 M(-15.7%) |
Mar 2024 | - | $207.38 M(+16.2%) |
Dec 2023 | $608.75 M(+11.5%) | $178.41 M(+10.5%) |
Sep 2023 | - | $161.51 M(+12.0%) |
Jun 2023 | - | $144.21 M(+15.7%) |
Mar 2023 | - | $124.62 M(+1.0%) |
Dec 2022 | $546.09 M(-15.5%) | $123.41 M(-0.8%) |
Sep 2022 | - | $124.44 M(-14.5%) |
Jun 2022 | - | $145.53 M(-4.7%) |
Mar 2022 | - | $152.71 M(-14.4%) |
Dec 2021 | $646.35 M | $178.50 M(+17.6%) |
Sep 2021 | - | $151.84 M(+2.6%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2021 | - | $148.04 M(-11.9%) |
Mar 2021 | - | $167.97 M(+31.6%) |
Dec 2020 | $482.73 M(+57.3%) | $127.61 M(-0.4%) |
Sep 2020 | - | $128.07 M(+2.8%) |
Jun 2020 | - | $124.57 M(+21.5%) |
Mar 2020 | - | $102.49 M(+10.8%) |
Dec 2019 | $306.80 M(+67.0%) | $92.46 M(+13.8%) |
Sep 2019 | - | $81.27 M(+17.2%) |
Jun 2019 | - | $69.32 M(+8.7%) |
Mar 2019 | - | $63.75 M(-2.8%) |
Dec 2018 | $183.66 M(+318.8%) | $65.58 M(+58.2%) |
Sep 2018 | - | $41.46 M(+19.2%) |
Jun 2018 | - | $34.78 M(-16.9%) |
Mar 2018 | - | $41.84 M |
Dec 2017 | $43.86 M | - |
FAQ
- What is BridgeBio Pharma annual total expenses?
- What is the all time high annual total expenses for BridgeBio Pharma?
- What is BridgeBio Pharma annual total expenses year-on-year change?
- What is BridgeBio Pharma quarterly total expenses?
- What is the all time high quarterly total expenses for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly total expenses year-on-year change?
What is BridgeBio Pharma annual total expenses?
The current annual total expenses of BBIO is $799.27 M
What is the all time high annual total expenses for BridgeBio Pharma?
BridgeBio Pharma all-time high annual total expenses is $799.27 M
What is BridgeBio Pharma annual total expenses year-on-year change?
Over the past year, BBIO annual total expenses has changed by +$190.52 M (+31.30%)
What is BridgeBio Pharma quarterly total expenses?
The current quarterly total expenses of BBIO is $227.22 M
What is the all time high quarterly total expenses for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly total expenses is $227.22 M
What is BridgeBio Pharma quarterly total expenses year-on-year change?
Over the past year, BBIO quarterly total expenses has changed by +$37.35 M (+19.67%)